Biospace
Published November 18, 2026
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating ...
Read the full story at Biospace
This press release contains forward-looking statements within the ... Delix raises $100M to advance at-home psychedelic without hallucinogenic effects.
Surfaced by this Google Alert
- Psychedelic press release